GRI Bio, Inc. (GRI)

↓ Download CSV

CIK 0001824293 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

Key ratios (FY2025)

-199.0%
Return on equity
Metric (FY)2025202420232022202120202019
Revenue$0$100.0K
Operating Income-$11.98M-$8.23M-$11.39M-$2.24M-$9.26M-$4.79M
Net Income-$11.96M-$8.21M-$13.04M-$3.22M-$9.30M-$4.82M
EPS (Diluted)$-121.80$-1545.55$-5018.09$-24.95$-1.42$-1.07
Total Assets$8.67M$5.74M$2.96M$383.0K$8.34M$955.0K
Total Liabilities$2.66M$1.71M$2.70M$2.01M$2.52M$2.41M
Shareholders' Equity$6.01M$4.03M$259.0K-$1.62M-$4.85M-$1.45M$3.21M
Cash & Equivalents$8.23M$5.03M$1.81M$9.0K$3.70M$109.0K
Operating Cash Flow-$10.19M-$8.61M-$8.99M-$1.08M-$8.31M-$3.71M
Capital Expenditures$3.0K$0$8.0K$3.0K$0$2.0K
Shares Outstanding497.7K18.8K2.9K142.8K6.81M4.51M